HIV/AIDS

Product selection/Rational use

Selection

WHO produced a set of guidelines that addresses treatment regimens and operational concerns for antiretroviral treatment (ART) scale up in countries. The treatment guidelines are intended to support and facilitate proper management and rapid scale up of ART programs.

Correct use of drugs by patients is critical for effectiveness of antiretroviral treatment. The rational use of drugs involves medications available at the lowest possible cost, prescribed to meet patients' individual clinical needs, given in appropriate doses and for adequate period of time.

Sources of antiretrovirals (ARVs)

Information on sources and prices of ARVs are subject to periodic changes in view of the continuous and rapid introduction of new products and new product combinations on the market.

Various documents on sources and prices of selected ARVs are available, as for example: "Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS" produced by UNICEF, 2007 and "Untangling the Web of Price Reductions, MSF, July 2007 / 10th edition (September 2007 revision)"by MSF. Furthermore, the Global Fund to fight AIDS, Tuberculosis and Malaria published the Global Fund Purchase Price report which presents the prices that Global Fund grant recipients paid for ARVs and diagnostics for their programmes. Another comprehensive tool to compare ARV prices in countries is the Global Price Monitoring Mechanism operated by AMDS partners.

Treatment guidelines and technical tools

Antiretrovirals and essential medicines


Share